Case Study No. 2


“Great product, you almost notice immediate impact on patient. It’s a highly specialty product,
hugh medical need for it but it’s quite expensive. How best to approach the PBS submission? Who can help us?”

CEO of Global Pharmaco


Case: Specialty product pricing


Medical need; S100 category; pre-meetings with KOLs and Authority; global price and reimbursement status; risk/benefit price analysis; RSA (Risk Share Agreement)


  • Acceptance, positive feedback and support for price submission from KOLs
  • Effective cooperation of global and national pricing managers
  • Strategic input and feedback from pre-meetings
  • Substantiated price submission on time
  • RSA negotiations
  • Reimbursement in second attempt (above average)


back >> next Case Study